3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
15
Terminated
6
Withdrawn
2
Recruiting
1
No longer available
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Hodgkin Disease
8
Mycosis Fungoides
3
Lymphoma, T-Cell, Peripheral
3
Recurrence
2
Lymphoma, T-Cell, Cutaneous
2
Sezary Syndrome
1
Mesothelioma, Malignant
1
Lymphomatoid Papulosis
1
Lymphoma, T-Cell
1
Lymphoma, Large-Cell, Anaplastic
1
Lymphoma, Follicular
1
Lymphoma
1
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
1
Leukemia, Large Granular Lymphocytic
1
Interventions
Magnetic Resonance Spectroscopy
4
Specimen Handling
3
Cyclophosphamide
3
Biopsy
3
sodium-iodide symporter
2
fludarabine
2
cemiplimab
2
alectinib
2
X-Rays
2
Stem Cell Transplantation
2
Photons
2
Nivolumab
2
Immunoglobulin G
2
Disulfides
2
treosulfan
1
sargramostim
1
ruxolitinib
1
repotrectinib
1
duvelisib
1
brigatinib
1
belinostat
1
Whole-Body Irradiation
1
Vinblastine
1
Suspensions
1
Standard of Care
1
Practice Guidelines as Topic
1
Positron-Emission Tomography
1
Mycophenolic Acid
1
Leukapheresis
1
Ipilimumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Lymphoma, Large-Cell, Anaplastic
×
Brentuximab Vedotin
×
Clear all
NCT07013565
2026-05-20
ACCELERATE
New York Medical College
Phase 2
Recruiting
20 enrolled